Drugs / Bromazepam
last change Jun 2025 re-read 2 minutes ago

Bromazepam

Small molecule targets GABRA2 via activation

Developed for
depressive disorder · schizophrenia · anxiety · bipolar disorder · personality disorder · post-traumatic stress disorder
Investigated by
Hannover Medical School · Rakitzi, Stavroula

Trials 2 · a red edge is where a trial was stopped

20152016201720182019202020212022202320242025202620272028
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 11 trial
Phase 1 NCT06993662 Jun 2025 → Dec 2027 expected anxiety, bipolar disorder, depressive disorder, obsessive-compulsive disorder +3 Rakitzi, Stavroula Active not recruiting No outcome recorded
Phase 31 trial
Phase 3 NCT02374567 Jan 2015 → Jun 2017 anxiety disorder, dementia, depressive disorder, schizophrenia +1 Hannover Medical School Terminated No outcome recorded
Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT04410536 Background Jun 2020 → Dec 2021 migraine disorder Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta Completed No outcome recorded

Evidence & citations 12 cited values

Every value below carries the sentence it was read from. 4 sources stand behind the page.

FieldValueCited text
Known as Bromazepam bromazepam 1.5 mg, 1 tablet after breakfast, lunch and dinner for every day” NCT04410536
1

NCT02374567

Known as Bromazepam civ ChEMBL registry synonym — accepted as the source's own label CHEMBL277062
Known as Lectopam ChEMBL registry synonym — accepted as the source's own label CHEMBL277062
Known as Lexatin ChEMBL registry synonym — accepted as the source's own label CHEMBL277062
Known as Lexotan ChEMBL registry synonym — accepted as the source's own label CHEMBL277062
Known as lexotanil “The combination of pharmacotherapy (anxiolytics (Tavor, clonotril, lexotanil), antidepressants (SSRI, SNRI)) and individual cognitive behavioral psychotherapy by anxiety...” NCT06993662
Known as NSC-140669 ChEMBL registry synonym — accepted as the source's own label CHEMBL277062
Known as RO 5-3350 ChEMBL registry synonym — accepted as the source's own label CHEMBL277062
Action Activate “GABA receptor alpha-2 subunit positive allosteric modulator” CHEMBL277062
Modality Small molecule CHEMBL277062
Route Oral oral administration of a bridge therapy to reduce the withdrawal symptoms and rebound headache (prednisone 25 mg , 2 tablets after breakfast for 5 days, one tablet for 3 days,...” NCT04410536
Target GABRA2 “GABA receptor alpha-2 subunit positive allosteric modulator” CHEMBL277062